Design and synthesis of paclitaxel conjugated with an ErbB2-recognizing peptide, EC-1

Biopolymers

Volumn 87, Issue 4, 2007, Pages 225-230

  Li, Peng ^a,c   Jiang, Sheng ^a   Pero, Stephanie C ^b   Oligino, Lyn ^b   Krag, David N ^b   Michejda, Christopher J ^a   Roller, Peter P ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c Intra Cellular Therapies Inc   (United States)

Author keywords

Conjugate; Cyclic peptide EC 1; Disulfide; erbB2; Paclitaxel

Indexed keywords

BREAST CANCER CELLS; CYCLIC PEPTIDE EC-1; CYCLOPEPTIDES; DISULFIDE; THERAPEUTIC AGENTS;

CELL PROLIFERATION; CYTOTOXICITY; ONCOLOGY; SYNTHESIS (CHEMICAL);

PEPTIDES;

CYCLOPEPTIDE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; PACLITAXEL; PROTEIN; PROTEIN EC 1; UNCLASSIFIED DRUG;

ARTICLE; DRUG CONJUGATION; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; PROTEIN BINDING; UNSPECIFIED SIDE EFFECT;

BREAST NEOPLASMS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; FEMALE; HUMANS; PACLITAXEL; PEPTIDES, CYCLIC; RECEPTOR, ERBB-2;

EID: 35949003541     PISSN: 00063525     EISSN: 10970282     Source Type: Journal    
DOI: 10.1002/bip.20828     Document Type: Article

References (33)

1. Wani, M. C.; Taylor, H. L.; Wall, M. E.; Coggon, P.; McPhail, A. T. J Am Chem Soc 1971, 93, 2325-2327.
2. Cortes, J. E.; Pazdur, R. Docetaxel. J Clin Oncol 1995, 13, 2643-2655.
3. Yarboro, J. W.; Bornstein, R. S.; Mastrangelo, M. J., Eds. Paclitaxel (Taxol): Current Practices and Future Directions in Breast Cancer Management; Seminars in Oncology; Saunders: Philadelphia, PA, 1996; Vol. 23(1, Suppl. 14), pp 23-31.
4. Georg, G. I.; Chen, T. T.; Ojima, I.; Vyas, D. M., Eds. Taxane Anticancer Agents: Basic Science and Current Status; ACS Symposium Series 583; American Chemical Society: Washington, DC, 1995.
5. Suffness, M., Ed. Taxol Science and Applications; CRC Press: Boca Raton, FL, 1995.
6. Diaz, J. F.; Andreu, J. M. Biochemistry 1993, 32, 2747-2755.
7. Schiff, P. B.; Fant, J.; Horwitz, S. B. Nature 1979, 277, 665-667.
8. Kusama, H.; Hara, R.; Kawahara, S.; Nishimori, T.; Kashima, H.; Nakamura, N.; Morihira, K.; Kuwajima, I. J Am Chem Soc 2000, 122, 3811-3820, and references cited therein.
9. Rodi, D. J.; Janes, R. W.; Sanganee, H. J.; Holton, R. A.; Wallace, B. A.; Makowski, L. J Mol Biol 1999, 285, 197-203.
10. Guillemard, V.; Saragovi, H. U. Curr Cancer Drug Targets 2004, 4, 313-326.
11. Ranson, M.; Jayson, G. Br J Cancer 2005, 92(Suppl 1), S28-S31.
12. Green, M. C.; Murray, J. L.; Hortobagyi, G. N. Cancer Treat Rev 2000, 26, 269-286.
13. Lin, M. Z.; Teitell, M. A.; Schiller, G. J. Clin Cancer Res 2005, 11, 129-138.
14. Garrett, M. D.; Workman, P. Eur J Cancer 1999, 35, 2010-2030.
15. Stefanidakis, M.; Koivunen, E. Curr Pharm Des 2004, 10, 3033-3044.
16. Langer, M.; Kratz, F.; Rothen-Rutishauser, B.; Wunderli-Allenspach, H.; Beck-Sickinger, A. G. J Med Chem 2001, 44, 1341-1348.
17. Safavy, A.; Bonner, J. A.; Waksal, H. W.; Buchsbaum, D. J.; Gillespie, G. Y.; Khazaeli, M. B.; Arani, R.; Chen, D. T.; Carpenter, M.; Raisch, K. P. Bioconjugate Chem 2003, 14, 302-310.
18. Safavy, A.; Georg, G.; Velde, D. V.; Raisch, K. P.; Safavy, K.; Carpenter, M.; Wang, W.; Bonner, J. A.; Khazaeli, M. B.; Buchsbaum, D. J. Bioconjugate Chem 2004, 15, 1264-1274.
19. Pasqualini, R.; Ruoslahti, E. Nature 1996, 380, 364-366.
20. Chen, X.; Plasencia, C.; Hou, Y.; Neamati, N. J Med Chem 2005, 48, 1098-1106.
21. Safavy, A.; Raisch, K. P.; Matusiak, D.; Bhatnagar, S.; Helson, L. Bioconjugate Chem 2006, 17, 565-570.
22. Moffatt, S.; Wiehle, S.; Cristiano, R. J Hum Gene Ther 2005, 16, 57-67.
23. Kolonin, M.; Pasqualini, R.; Arap, W. Curr Opin Chem Biol 2001, 5, 308-313.
24. Goodwin, D. A.; Meares, C. F. Cancer Biother Radiopharm 1999, 14, 145-152.
25. Buchsbaum, D. J. Semin Nucl Med 2004, 34, 32-46.
26. Ullrich, A.; Schlessinger, J. Cell 1990, 61, 203-212.
27. Plowman, G. D.; Culouscou, J. M.; Whitney, G. S.; Green, J. M.; Carlton, G. W.; Foy, L.; Neubauer, M. G.; Shoyab, M. Proc Natl Acad Sci USA 1993, 90, 1746-1750.
28. Braun, S.; Schlimok, G.; Heumos, I.; Schaller, G.; Riethdorf, L.; Riethmüller, G.; Pantel, K. Cancer Res 2001, 61, 1890-1895.
29. Pero, S. C.; Shukla, G. S.; Armstrong, A. L.; Peterson, D.; Fuller, S. P.; Godin, K.; Kingsley-Richards, S. L.; Weaver, D. L.; Bond, J.; Krag, D. N. Int J Cancer 2004, 111, 951-960.
30. Maruyama, T.; Ikeo, T.; Ueki, M. Tetrahedron Lett 1999, 40, 5031-5034.
31. The reaction mixture was directly injected into a semipreparative HPLC after a 5-min reaction period. Each peak was collected and analyzed by MALDI-TOF mass spectrometer and compared with reference compounds (data not shown).
32. Kunz, H.; Waldmann, H. Angew Chem Int Ed Engl 1984, 23, 71-72.
33. Kunz, H.; März, J. Synlett 1992, 591-593.